arrow
J

Jordan J. Feld

University Health Network
H指数:83
被引数:2.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development and silent trial of DynaMELD, a Dynamic Model of End-Stage Liver Disease for personalized waitlist prioritization

DynaMELD的开发与静默试验,一种用于个性化等待名单优先排序的终末期肝病动态模型

2026-11-070
OA
Short-course prophylaxis with the Toronto HCV protocol for recipients of non-liver solid organ transplants from donors with hepatitis C viraemia: a retrospective, matched cohort study

对来自丙型肝炎病毒血症供体的非肝脏实体器官移植受者应用多伦多HCV方案进行短期预防:一项回顾性、匹配队列研究

2026-09-290
PRE
Implementation of Integrated hepatitis C Test and Treat with Peer Support in Opioid Treatment Programs: A qualitative RE-AIM evaluation of staff perspectives.

在阿片类药物治疗项目中实施整合丙型肝炎检测与治疗及同伴支持:一项关于员工视角的定性RE-AIM评估。

2026-09-080
PRE
Hepatitis C virus infection dynamics; treatment; and lipid nanoparticle–mediated infection in humanized liver chimeric mouse models

丙型肝炎病毒感染动力学、治疗及脂质纳米颗粒介导的感染在人类化肝脏嵌合小鼠模型中

2026-05-290
OA
Rapid hepatitis C test and treat with peer support at opioid treatment programs (RAPID HCV): a hybrid effectiveness-implementation type 1 randomized control trial

快速丙型肝炎检测与治疗及同伴支持在阿片类药物治疗项目中的应用(RAPID HCV):一项混合型有效性-实施类型1随机对照试验

2026-03-240
OAAI
Utility of Serum Biomarkers in Addition to Ultrasound for Early Detection of Hepatocellular Carcinoma in High-Risk Patients: A Randomized Controlled Trial

血清生物标志物联合超声对肝癌高危患者早期检测的效用: 一项随机对照试验

2026-01-200
PRE
Pharmacist-Led Hepatitis C Diagnosis and Rapid Management-In Community (PHARM-C): Results From a Phase IV Nonblinded Randomised Controlled Trial

药师主导的丙型肝炎诊断和快速管理—社区研究(PHARM-C):一项IV期非盲随机对照试验的结果

2026-01-010
OAAI
A Rapid Assay for Hepatitis C Virus RNA Detection Using Reverse-Transcription Loop-Mediated Isothermal Amplification-Coupled CRISPR-Cas12b-Based Strategy

使用逆转录环介导等温扩增偶联CRISPR-Cas12b-Based策略快速检测丙型肝炎病毒RNA

2026-01-010
PRE
A liver gene signature links liver cancer risk in chronic viral hepatitis to intrahepatic IgA plasma cells

肝脏基因签名将慢性病毒性肝炎的肝癌风险与肝内IgA浆细胞联系起来

2025-12-190
OAAI
Tenofovir alafenamide for prevention of HBV reactivation in HBsAg-negative, anti–HBc-positive patients undergoing rituximab-based chemotherapy: A multicenter randomized controlled trial

替诺福韦艾拉酚胺用于预防HBsAg阴性、抗-HBc阳性患者接受利妥昔单抗为基础化疗时HBV再激活:一项多中心随机对照试验

2025-12-030
OAAI
AASLD/IDSA Practice Guideline on treatment of chronic hepatitis B

AASLD/IDSA 实践指南:慢性乙型肝炎的治疗

2025-11-014
PRE